For instance, 90Y-anti-CD20 and 213Bi-anti-CD33 bind to CD20 and CD33, respectively, in lymphomas and leukemias, while 177Lu-trastuzumab binds to the HER2 receptor in breast cancer. Here, CD33 is linked to leukemia.